References
- Balakumar, P., Sharma, R., and Singh, M., 2008. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. Pharmacological research, 58, 356–363.
- Beyer, A.M., Guo, D.F., and Rahmouni, K., 2013. Prolonged treatment with angiotensin 1-7improves endothelial function in diet-induced obesity. Journal of hypertension, 31, 730–738.
- Burger, D. and Touyz, R.M., 2012. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. Journal of the American society of hypertension, 6, 85–99.
- Cannon, C.P. and Cannon, P.J., 2012. Physiology. COX-2 inhibitors and cardiovascular risk. Science (New York, N.Y.), 336, 1386–1387.
- Cruz, M.A., et al., 1997. Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation. Placenta, 18, 197–204.
- Datté, J.Y., Yapo, P.A., and Offoumou, M.A., 2005. Nitric oxide effect on 5-hydroxytryptamine-induced vasoconstrictions of isolated smooth muscle. Pharmacological reports, 57, 113–120.
- Dick, F., et al., 2007. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. Journal of vascular surgery, 45, 751–761.
- European Stroke Organisation, ESC Committee for Practice Guidelines, Tendera, M., et al., 2011. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). European heart journal, 32, 2851–2906.
- Festing, M.F. and Altman, D.G., 2005. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR Journal, 43, 244–258.
- Gerhard-Herman, M.D., et al., 2016. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Circulation, 135, e686–e725.
- Ibarra, M., et al., 2006. Endothelium-dependent inhibition of the contractile response is decreased in aorta from aged and spontaneously hypertensive rats. Archives of medical research, 37, 334–341.
- Jespersen, B., Knupp, L., and Northcott, C.A., 2012. Femoral arterial and venous catheterization for blood sampling, drug administration and conscious blood pressure and heart rate measurements. Journal of visual experiments, 59, pii: 3496. doi: 10.3791/3496.
- Jones, M.R., et al., 2013. Smoking, menthol cigarettes, and peripheral artery disease in U.S. adults. Nicotine and tobacco research, 15, 1183–1189.
- Kanagy, N.L., Mecca, T.E., and Webb, R.C., 1996. Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats. Blood pressure, 5, 113–120.
- Lee, R.M., et al., 2009. Alteration of perivascular adipose tissue function in angiotensin II-induced hypertension. Canadian journal of physiology and pharmacology, 87, 944–953.
- Li, W., et al., 2013. Apobec-1 increases cyclooxygenase-2 and aggravates injury in oxygen-deprived neurogenic cells and middle cerebral artery occlusion rats. Neurochemical research, 38, 1434–1445.
- Lin, P.J., et al., 1991. Superoxide anion mediates the endothelium-dependent contractions to serotonin by regenerated endothelium. The journal of thoracic and cardiovascular surgery, 102, 378–385.
- Lin, Y., et al., 2017. Hydrogen Sulfide attenuates atherosclerosis in a partially ligated carotid artery mouse model via regulating angiotensin converting enzyme 2 expression. Frontiers in physiology, 8, 782.
- Liskova, S., et al., 2014. Contribution of Ca2+-dependent Cl− channels to norepinephrine-induced contraction of femoral artery is replaced by increasing EDCF contribution during ageing. Biomedical research international, 2014, 289361.
- Líšková, S., et al., 2011. Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. European journal of pharmacology, 667, 265–270.
- Luo, H.L., et al., 2006. The protective effect of captopril on nicotine-induced endothelial dysfunction in rat. Basic & clinical pharmacology & toxicology, 99, 237–245.
- Marso, S.P. and Hiatt, W.R., 2006. Peripheral arterial disease in patients with diabetes. Journal of the American college of cardiology, 47, 921–929.
- Matsumoto, T., et al., 2014. Mechanisms underlying increased serotonin-induced contraction in carotid arteries from chronic type 2 diabetic Goto-Kakizaki rats. Pharmacological research, 87, 123–132.
- Miyazaki, M., et al., 2007. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. Journal of cardiovascular pharmacology, 49, 221–227.
- Nelson, P.M., Harrod, J.S., and Lamping, K.G., 2012. 5HT(2A) and 5HT(2B) receptors contribute to serotonin-induced vascular dysfunction in diabetes. Experimental diabetes research, 2012, 398406.
- Ni, W., et al., 2008. The existence of a local 5-hydroxytryptaminergic system in peripheral arteries. British journal of pharmacology, 154, 663–674.
- Perry, P., 2007. The ethics of animal research: a UK perspective. ILAR Journal, 48, 42–46.
- Quartu, M., et al., 2017. Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion. Lipids in health and disease, 16, 14.
- Radenković, M., Stojanović, M., and Topalović, M., 2010. Contribution of thromboxane a2 in rat common carotid artery response to serotonin. Scientia pharmaceutica, 78, 435–443.
- Radenković, M., 2012. Ethics in preclinical and clinical drug development. In: Z. Todorovic, M. Prostranamd, K. Turza, eds. Kerala, India: Transworld Research Network, 43–50.
- Radenković, M., et al., 2013a. Effects of diabetes and vascular occlusion on adenosine-induced relaxant response of rat common carotid artery. Pharmacological reports, 65, 632–641.
- Radenković, M., et al., 2013b. Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art. BioMed research international, 2013, 252158.
- Radenković, M., Stojanović, M., and Prostran, M., 2016a. Experimental diabetes induced by alloxan and streptozotocin: the current state of the art. Journal of pharmacological and toxicological methods, 78, 13–31.
- Radenković, M., et al., 2016b. Angiotensin receptor blockers & endothelial dysfunction: possible correlation & therapeutic implications. Indian journal of medical research, 144, 154–168.
- Roganović, J., et al., 2011. Impairment of acetylcholine-mediated endothelium-dependent relaxation in isolated parotid artery of the alloxan-induced diabetic rabbit. European journal of oral sciences, 119, 352–360.
- Ruan, C.H., et al., 2010. Prostacyclin therapy for pulmonary arterial hypertension. Texas heart institute journal, 37, 391–399.
- Senol, S. and Es, M.U., 2015. Is serotonin a valuable parameter in peripheral arterial disease? Asian cardiovascular & thoracic annals, 23, 289–291.
- Stojanović, M., et al., 2017. Clarification of serotonin-induced effects in peripheral artery disease observed through the femoral artery response in models of diabetes and vascular occlusion: the role of calcium ions. Clinical and experimental pharmacology & physiology, 44, 749–759.
- Triggle, C.R., et al., 2012. Theendothelium: influencing vascular smooth muscle in many ways. Canadian journal of physiology and pharmacology, 90, 713–738.
- Ugidos, I.F., et al., 2017. Neuroprotective effect of 2-hydroxy arachidonic acid in a rat model of transient middle cerebral artery occlusion. Biochim biophys acta, 1859 (9 Pt B), 1648–1656.
- Vischer, U.M., 2006. von Willebrand factor, endothelial dysfunction, and cardiovascular disease. Journal of thrombosis and haemostasis, 4, 1186–1193.
- Watanabe, T., et al., 2001a. Serotonin potentiates angiotensin II–induced vascular smooth muscle cell proliferation. Atherosclerosis, 159, 269–279.
- Watanabe, T., et al., 2001b. Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation. Journal of hypertension, 19, 731–799.
- Zhang, L. and Hu, X.Q., 1998. Endothelium-dependent potentiation by cocaine of serotonin-induced contractions in sheep fetal umbilical artery. Journal of the society for gynecologic investigation, 5, 72–74.